Literature DB >> 21576928

Immunosenescence of human natural killer cells.

Inmaculada Gayoso1, Beatriz Sanchez-Correa, Carmen Campos, Corona Alonso, Alejandra Pera, Javier G Casado, Sara Morgado, Raquel Tarazona, Rafael Solana.   

Abstract

Natural killer (NK) cells are a key component of innate immunity involved not only in the elimination of virus-infected or tumor cells but also in the regulation of the immune response by producing cytokines and chemokines that can activate other cellular components of innate and adaptive immunity. NK cell subsets are differentially affected by aging. Whereas CD56(bright) cells are decreased in healthy elderly individuals, the CD56(dim) subset is expanded. The expression of CD57, a marker of highly differentiated NK cells, is increased in the elderly; this supports the notion that a remodeling process of NK cell subsets occurs in aging with a gradual decrease in more immature CD56(bright) NK cells and an increase in highly differentiated CD56(dim) CD57+ NK cells. This NK cell redistribution can explain many of the phenotypic and functional changes in NK cells associated with healthy aging such as decreased proliferation and the maintenance of CD16-dependent cytotoxicity.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576928     DOI: 10.1159/000328005

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  60 in total

1.  Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.

Authors:  Shoko Nogusa; Donna M Murasko; Elizabeth M Gardner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-27       Impact factor: 6.053

2.  Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

Authors:  Esther M de Kruijf; Esther Bastiaannet; Francesca Rubertá; Anton J M de Craen; Peter J K Kuppen; Vincent T H B M Smit; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  Mol Oncol       Date:  2014-04-08       Impact factor: 6.603

3.  Nutritional and Physical Activity Interventions to Improve Immunity.

Authors:  Glen Davison; Corinna Kehaya; Arwel Wyn Jones
Journal:  Am J Lifestyle Med       Date:  2014-11-25

Review 4.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 5.  Aging of the immune system: Focus on inflammation and vaccination.

Authors:  Marcello Pinti; Victor Appay; Judith Campisi; Daniela Frasca; Tamas Fülöp; Delphine Sauce; Anis Larbi; Birgit Weinberger; Andrea Cossarizza
Journal:  Eur J Immunol       Date:  2016-10       Impact factor: 5.532

Review 6.  Age has a role in driving host immunopathological response to alphavirus infection.

Authors:  Yi-Hao Chan; Lisa F P Ng
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

7.  Expression of cellular protective proteins SIRT1, HSP70 and SOD2 correlates with age and is significantly higher in NK cells of the oldest seniors.

Authors:  Lucyna Kaszubowska; Jerzy Foerster; Jan Jacek Kaczor; Daria Schetz; Tomasz Jerzy Ślebioda; Zbigniew Kmieć
Journal:  Immun Ageing       Date:  2017-01-23       Impact factor: 6.400

8.  Human immunophenotyping via low-variance, low-bias, interpretive regression modeling of small, wide data sets: Application to aging and immune response to influenza vaccination.

Authors:  Tyson H Holmes; Xiao-Song He
Journal:  J Immunol Methods       Date:  2016-05-16       Impact factor: 2.303

9.  Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation.

Authors:  K Backteman; J Ernerudh; L Jonasson
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 10.  How the ageing microenvironment influences tumour progression.

Authors:  Mitchell Fane; Ashani T Weeraratna
Journal:  Nat Rev Cancer       Date:  2019-12-13       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.